Cromos Pharma began managing clinical research in Georgia in 2013. Since then, our Tbilisi-based operation has grown exponentially, managing numerous successful regional and global studies in a broad range of therapeutic areas.
|Lightning fast approval process. Georgia's regulatory approval process takes on average about two months.|
|Georgia's rapidly growing study-related workforce is well experienced in international, ICH GCP-compliant clinical trials.|
|Georgia's investment in the healthcare sector over the last decade has increased the number of medical facilities and in-patient beds.|
Most hospitals are well-equipped, and the staff is eager to participate in clinical research.
|Good recruitment potential due to an ethnically diverse population with treatment- naive patients in a range of therapeutic areas.|
Georgia's costs of clinical research are much lower than the US or Western Europe.
|Economic and political reforms have made Georgia an attractive and welcoming destination for international companies seeking to do business there.|
|Investigators and their patients are highly motivated to participate in trials as a way of accessing novel therapies not yet available through the national health system.|
Fourteen different therapeutic areas including:
Heart Disease, brain diseases, central nervous system diseases, neurological diseases, RNA infections and other viruses.
Georgia boasts an impressively rapid regulatory study approval process (<2 months from submission to study start). This rapid startup timeline, combined with a pool of skilled and professional medical staff, full compliance with ICH GCP standards and a solid reputation for producing high quality results make Georgia a very attractive prospect for sponsors.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.